ALAMEDA,
Calif., Aug. 2, 2024 /PRNewswire/ -- Penumbra,
Inc. (NYSE: PEN) today announced that its management team is
scheduled to present at the Canaccord Genuity Growth Conference on
Tuesday, August 13, 2024.
Event: Canaccord Genuity Growth
Conference
Date: Tuesday, August 13, 2024
Time: 9:00am ET/6:00am PT
A webcast of the presentation can be accessed on the "Events and
Presentations" section under the "Investors" tab of the company's
website at www.penumbrainc.com. The webcast will be available on
the company's website for at least two weeks following the
event.
About Penumbra
Penumbra, Inc., the world's
leading thrombectomy company, is focused
on developing the most innovative technologies for challenging
medical conditions such as ischemic
stroke, venous thromboembolism such
as pulmonary embolism, and acute limb
ischemia. Our broad portfolio, which includes
computer assisted vacuum thrombectomy
(CAVT), centers on removing blood
clots from head-to-toe with speed, safety and simplicity. By
pioneering these innovations, we support healthcare providers,
hospitals and clinics in more than 100 countries, working to
improve patient outcomes and quality of life. For more information,
visit www.penumbrainc.com and connect on
Instagram, LinkedIn and
X.
Investor Relations
Penumbra, Inc.
investors@penumbrainc.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-canaccord-genuity-growth-conference-302213644.html
SOURCE Penumbra, Inc.